Alexandria Venture Investments rated top firm for biopharma, healthcare

Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities Inc., has been recognized by Silicon Valley Bank as the most active biopharma investor by new deal volume in 2017-2018 and also by Forbes as the #1 venture capital investor in the healthcare sector by U.S.-based deal volume in 2018. Click here to learn more about the fund that also invests in diagnostics, research tools, agtech, and related technologies.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.